ImmuPharma plc (AIM:IMM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
4.733
+0.333 (7.56%)
Jun 16, 2026, 12:21 PM GMT

ImmuPharma Balance Sheet

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.350.240.210.671.65
Cash & Short-Term Investments
1.350.240.210.671.65
Cash Growth
470.81%13.63%-68.78%-59.51%-71.86%
Accounts Receivable
---0.17-
Other Receivables
0.390.430.691.181.13
Receivables
0.390.430.691.341.13
Prepaid Expenses
0.070.060.020.070.05
Other Current Assets
-0.150.430.250.51
Total Current Assets
1.810.881.342.343.35
Property, Plant & Equipment
0.060.080.10.390.35
Long-Term Investments
--0.640.691.42
Other Intangible Assets
-0.010.040.070.07
Long-Term Deferred Charges
--0.40.40.4
Other Long-Term Assets
--0.180.080.41
Total Assets
1.880.982.723.976
Accounts Payable
0.190.510.781.071.16
Accrued Expenses
0.880.890.770.20.16
Short-Term Debt
---00
Current Portion of Long-Term Debt
----0
Current Income Taxes Payable
0.130.120.120.180.27
Total Current Liabilities
1.191.521.671.451.58
Total Liabilities
1.191.521.671.451.58
Common Stock
30.6829.8129.8128.9828.5
Additional Paid-In Capital
31.3629.3229.3228.7927.24
Retained Earnings
-67.72-65.91-64.08-61.12-56.58
Comprehensive Income & Other
6.376.246.015.875.26
Shareholders' Equity
0.69-0.541.062.524.41
Total Liabilities & Equity
1.880.982.723.976
Total Debt
---00
Net Cash (Debt)
1.350.240.210.671.65
Net Cash Growth
470.81%13.63%-68.78%-59.50%-68.42%
Net Cash Per Share
0.000.000.000.000.01
Filing Date Shares Outstanding
502.72416.44416.44333.4284.98
Total Common Shares Outstanding
502.72416.44416.44333.4284.98
Working Capital
0.62-0.64-0.320.891.76
Book Value Per Share
0.00-0.000.000.010.02
Tangible Book Value
0.69-0.551.012.454.34
Tangible Book Value Per Share
0.00-0.000.000.010.02
Machinery
0.150.140.191.261.1